Holen Sie sich die Stockscreener-App
8.665
0.63%
-0.055
Vorhandelsmarkt:
8.66
-0.005
-0.06%
Schlusskurs vom Vortag:
$8.72
Offen:
$8.7
24-Stunden-Volumen:
626.43K
Relative Volume:
0.34
Marktkapitalisierung:
$487.82M
Einnahmen:
$27.46M
Nettoeinkommen (Verlust:
$-46.05M
KGV:
-6.7171
EPS:
-1.29
Netto-Cashflow:
$-33.83M
1W Leistung:
+0.76%
1M Leistung:
-11.49%
6M Leistung:
-3.18%
1J Leistung:
-5.61%
1-Tages-Spanne:
$8.475
$8.80
1-Wochen-Bereich:
$8.12
$8.80
52-Wochen-Spanne:
$6.19
$13.16
Zevra Therapeutics Inc Stock (ZVRA) Company Profile
Firmenname
Zevra Therapeutics Inc
Sektor
Branche
Telefon
(321) 939-3416
Adresse
1180 CELEBRATION BOULEVARD, SUITE 103, CELEBRATION
Vergleichen Sie ZVRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZVRA
Zevra Therapeutics Inc
|
8.665 | 490.91M | 27.46M | -46.05M | -33.83M | -1.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Zevra Therapeutics Inc Stock (ZVRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-01-08 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2024-10-07 | Eingeleitet | Guggenheim | Buy |
| 2024-09-24 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-09-24 | Bestätigt | Maxim Group | Buy |
| 2024-04-02 | Bestätigt | Maxim Group | Buy |
| 2024-03-12 | Eingeleitet | William Blair | Outperform |
| 2023-03-17 | Eingeleitet | Maxim Group | Buy |
Alle ansehen
Zevra Therapeutics Inc Aktie (ZVRA) Neueste Nachrichten
How Zevra Therapeutics Inc. stock performs after earningsPortfolio Value Report & Expert Approved Momentum Ideas - Newser
Behavioral Patterns of ZVRA and Institutional Flows - news.stocktradersdaily.com
Does Zevra Therapeutics’ (ZVRA) Board Turnover Subtly Recast Its Leadership and Capital Allocation Narrative? - simplywall.st
Why Zevra Therapeutics Inc. stock is favored by top institutionsDollar Strength & Stepwise Entry and Exit Trade Signals - Newser
Legal & General Group Plc Grows Stock Position in Zevra Therapeutics, Inc. $ZVRA - MarketBeat
Zevra Therapeutics (ZVRA): Evaluating Valuation Following High-Profile Board Appointment and CFO Transition - simplywall.st
Zevra Therapeutics, Inc. Announces Director and Committee Changes, Effective as of December 2, 2025 - marketscreener.com
Zevra Therapeutics appoints Alicia Secor to board of directors; announces retirement of Wendy Dixon - marketscreener.com
Zevra Therapeutics Appoints Alicia Secor to Board - TipRanks
Zevra Therapeutics, Inc. Appoints Alicia Secor to Board of Directors; Announces Retirement of Wendy Dixon, PhD - The Manila Times
Zevra Therapeutics, Inc. Appoints Alicia Secor to Board of Directors, Announces Retirement of Wendy Dixon - Quiver Quantitative
How Zevra Therapeutics Inc. (1GDA) stock valuation compares with sectorQuarterly Portfolio Report & Growth Focused Entry Reports - Newser
How Zevra Therapeutics Inc. (1GDA) stock expands through international marketsGDP Growth & Verified High Yield Trade Plans - Newser
How institutional buying supports Zevra Therapeutics Inc. stock - moha.gov.vn
Zevra Therapeutics (ZVRA): Assessing Valuation After CFO Succession News Spurs Fresh Investor Interest - simplywall.st
(ZVRA) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
Zevra Therapeutics CFO Resignation Announced - The Globe and Mail
Will Zevra Therapeutics Inc. (1GDA) stock issue positive guidanceGlobal Markets & Daily Technical Forecast Reports - newser.com
Why Zevra Therapeutics Inc. stock could rally in 2025July 2025 Analyst Calls & Safe Entry Point Alerts - newser.com
Zevra Therapeutics Announces CFO Transition - citybiz
Zevra Therapeutics announces CFO transition - MSN
Zevra Therapeutics (ZVRA) CFO to Step Down, Shares Fall - GuruFocus
Zevra Therapeutics, Inc. announces CFO transition - marketscreener.com
[8-K] ZEVRA THERAPEUTICS, INC. Reports Material Event | ZVRA SEC FilingForm 8-K - Stock Titan
Zevra Therapeutics Announces Departure of CFO R. LaDuane Clifton, Effective December 31, 2025 - Quiver Quantitative
Zevra Therapeutics, Inc. Announces Chief Financial Officer R. LaDuane Clifton to Step Down, Effective December 31, 2025 - marketscreener.com
Zevra Therapeutics, Inc. Announces CFO Transition - Sahm
Visualizing Zevra Therapeutics Inc. stock with heatmapsJuly 2025 Market Mood & Breakout Confirmation Alerts - newser.com
Will Zevra Therapeutics Inc. (1GDA) stock return to pre crash levelsWeekly Profit Report & Growth Focused Investment Plans - newser.com
Does Zevra Therapeutics Inc. (1GDA) stock trade below intrinsic valueEarnings Beat & Safe Entry Zone Identification - newser.com
What the charts say about Zevra Therapeutics Inc. todayQuarterly Profit Summary & Long-Term Capital Growth Ideas - newser.com
Is Zevra Therapeutics Inc. (1GDA) stock a top hedge fund pick2025 Sector Review & High Yield Stock Recommendations - newser.com
How sentiment analysis helps forecast Zevra Therapeutics Inc.July 2025 Outlook & Short-Term High Return Strategies - newser.com
Can Zevra Therapeutics Inc. stock beat market expectations this quarterBuy Signal & Technical Pattern Based Signals - newser.com
Will Zevra Therapeutics Inc. stock outperform growth indexesJuly 2025 Pullbacks & Pattern Based Trade Signal System - newser.com
Zevra Therapeutics Reports Strong Q3 2025 Revenue Growth - MSN
Zevra Therapeutics Inc Stock Analysis and ForecastPrice-to-Earnings Ratio Insights & Free High Impact Stock Picks - earlytimes.in
Finanzdaten der Zevra Therapeutics Inc-Aktie (ZVRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.10%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):